Concepedia

Craig Banotai

CB

Statistics

Publications

9

Citations

1.1K

H-Index

9

Active since

1998

Affiliations

Pfizer (United States)(Current)

Craig Banotai is an author at Pfizer (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1998–2013

9

Publications

9

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition

Jeffrey F. Ohren, Huifen Chen, A.G. Pavlovsky et al. · Nature Structural & Molecular Biology · 2004 · 621 citations

, , +9

Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects

Adam R. Johnson, A.G. Pavlovsky, Daniel F. Ortwine et al. · Journal of Biological Chemistry · 2007 · 211 citations · Full text

, , +17

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore

J. Richard Miller, Steve Dunham, Igor Mochalkin et al. · Proceedings of the National Academy of Sciences · 2009 · 160 citations · Full text

, , +17

Characterization of substrate binding and catalysis in the potential antibacterial target <i>N</i>‐acetylglucosamine‐1‐phosphate uridyltransferase (GlmU)

Igor Mochalkin, Sandra Lightle, Yaqi Zhu et al. · Protein Science · 2007 · 43 citations · Full text

, , +17

Application of electrospray ionization mass spectrometry for studying human immunodeficiency virus protein complexes

Joseph A. Loo, Tod P. Holler, Susan K. Foltin et al. · Proteins Structure Function and Bioinformatics · 1998 · 24 citations

, , +17

1–5 of 9